Consistent with this, PBMCs collected from MS patients (and compared to healthy relatives) showed in average increased expression of TNFα, increased levels of H3cit8K9me3 at the promoter of this gene, and increased expression of PADI4. The gene discussed is PADI4; the disease is myeloid sarcoma.